RESUMEN
AIMS: To evaluate evidence for feasibility, acceptability and cost-effectiveness of diabetes telemedicine applications. METHODS: MEDLINE, EMBASE, PSYCHINFO, CINAHL, Cochrane, and INSPEC were searched using the terms diabetes and telemedicine for clinical studies using electronic transfer of blood glucose results in people with diabetes. The technology used, trial design and clinical outcome measures used were extracted for trials and prospective cohort studies. Randomized controlled trials with HbA(1c) as an outcome were pooled using standard meta-analytical methods. RESULTS: We identified 539 papers among which 32 papers described 10 prospective cohort studies, 12 parallel group randomized controlled trials (RCT), three crossover trials, and one non-parallel group trial. Only two studies described full details of randomization, blinding of outcomes and dropouts and withdrawals. Electronic transfer of glucose results appears feasible in a clinical setting. Only two of the RCTs included more than 100 patients, and only three extended to 1 year. Only one study was designed to show that telemedicine interventions might replace clinic interventions without deterioration in HbA(1c). Results pooled from the nine RCTs with reported data did not provide evidence that the interventions were effective in reducing HbA(1c) (-0.1%, 95% CI -0.4% to 0.04%). CONCLUSIONS: Telemedicine solutions for diabetes care are feasible and acceptable, but evidence for their effectiveness in improving HbA(1c) or reducing costs while maintaining HbA(1c) levels, or improving other aspects of diabetes management is not strong. Further research should seek to understand how telemedicine might enhance educational and self-management interventions and RCTs are required to examine cost-effectiveness.
Asunto(s)
Automonitorización de la Glucosa Sanguínea/métodos , Diabetes Mellitus/sangre , Telemedicina/métodos , Ensayos Clínicos como Asunto , Estudios de Cohortes , Diabetes Mellitus/tratamiento farmacológico , Diabetes Mellitus Tipo 1/sangre , Diabetes Mellitus Tipo 1/tratamiento farmacológico , Diabetes Mellitus Tipo 2/sangre , Diabetes Mellitus Tipo 2/tratamiento farmacológico , Hemoglobina Glucada/análisis , Humanos , Aceptación de la Atención de Salud , Ensayos Clínicos Controlados Aleatorios como Asunto , Proyectos de Investigación , Telemedicina/instrumentaciónRESUMEN
Biomedical engineering is a thriving academic and industrial subject in the United Kingdom and Republic of Ireland (UKRI). We describe how the EMBS UKRI Chapter and EMB Student Society UKRI are trying to support this field. Geographical constraints and the smaller number of biomedical engineering undergraduate students mean that the Chapter and Student Society have been formed at a national level, rather than the conventional University-based clubs and societies typical in North America. The style of events is also slightly different, with a focus on conferences rather than short events lasting less than one day, offering increased value for delegates who have to travel significant distances to attend. The UKRI Chapter and Student Society are cooperating with related organizations in the UKRI, as well as drawing on various resources, to build on what has been achieved to date.